Bioventus Inc. (BVS) reported Q4 Revenue ; Offers Guidance

Bioventus Inc. (NASDAQ: BVS) reported Q4 Revenue for the quarter came in at $153.64 million versus the consensus estimate of $145.16 million.

GUIDANCE:

Bioventus Inc. sees FY2025 EPS of $0.64-$0.68, versus the consensus of $0.55. Bioventus Inc. sees FY2025 revenue of $560-570 million, versus the consensus of $554.8 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• HSBC Downgrades Iflytek Co Ltd (002230:CH) to Hold
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh